BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19699855)

  • 1. The Cholesterol, Hypertension, and Glucose Education (CHANGE) study for African Americans with diabetes: study design and methodology.
    Powers BJ; King JL; Ali R; Alkon A; Bowlby L; Edelman D; Gentry P; Grubber JM; Koropchak C; Maciejewski ML; McCant F; McKoy G; Newell M; Oddone EZ; Olsen MK; Rose CM; Trujillo G; Bosworth HB
    Am Heart J; 2009 Sep; 158(3):342-8. PubMed ID: 19699855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cholesterol, Hypertension, And Glucose Education (CHANGE) study: results from a randomized controlled trial in African Americans with diabetes.
    Crowley MJ; Powers BJ; Olsen MK; Grubber JM; Koropchak C; Rose CM; Gentry P; Bowlby L; Trujillo G; Maciejewski ML; Bosworth HB
    Am Heart J; 2013 Jul; 166(1):179-86. PubMed ID: 23816038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology-Intensified Diabetes Education Study (TIDES) in African Americans with type 2 diabetes: study protocol for a randomized controlled trial.
    Williams JS; Lynch CP; Knapp RG; Egede LE
    Trials; 2014 Nov; 15():460. PubMed ID: 25425504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
    Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
    Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially modifiable metabolic factors and the risk of cardiovascular disease hospitalizations in urban African Americans with diabetes.
    Cook CB; Hentz JG; Tsui C; Ziemer DC; Naylor DB; Miller WJ
    Ethn Dis; 2006; 16(4):852-8. PubMed ID: 17061737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peer-Led, Empowerment-Based Approach to Self-Management Efforts in Diabetes (PLEASED): A Randomized Controlled Trial in an African American Community.
    Tang TS; Funnell MM; Sinco B; Spencer MS; Heisler M
    Ann Fam Med; 2015 Aug; 13 Suppl 1(Suppl 1):S27-35. PubMed ID: 26304969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart matters: Gender and racial differences cardiovascular disease risk factor control among veterans.
    Goldstein KM; Melnyk SD; Zullig LL; Stechuchak KM; Oddone E; Bastian LA; Rakley S; Olsen MK; Bosworth HB
    Womens Health Issues; 2014; 24(5):477-83. PubMed ID: 25213741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design: telephone-delivered behavioral skills interventions for Blacks with Type 2 diabetes.
    Egede LE; Strom JL; Durkalski VL; Mauldin PD; Moran WP
    Trials; 2010 Mar; 11():35. PubMed ID: 20350322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved outcomes in diabetes care for rural African Americans.
    Bray P; Cummings DM; Morrissey S; Thompson D; Holbert D; Wilson K; Lukosius E; Tanenberg R
    Ann Fam Med; 2013; 11(2):145-50. PubMed ID: 23508601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial.
    Shi X; He J; Lin M; Liu C; Yan B; Song H; Wang C; Xiao F; Huang P; Wang L; Li Z; Huang Y; Zhang M; Chen CS; Obst K; Li W; Yang S; Yao G; Li X
    Am Heart J; 2021 Aug; 238():45-58. PubMed ID: 33957103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma markers of inflammation and prediction of cardiovascular disease and mortality in African Americans with type 1 diabetes.
    Roy MS; Janal MN; Crosby J; Donnelly R
    Diabetes Res Clin Pract; 2016 Apr; 114():117-25. PubMed ID: 26806456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.
    Cook CB; Erdman DM; Ryan GJ; Greenlund KJ; Giles WH; Gallina DL; El-Kebbi IM; Ziemer DC; Ernst KL; Dunbar VG; Phillips LS
    Diabetes Care; 2000 Mar; 23(3):319-24. PubMed ID: 10868858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of DECIDE (Decision-making Education for Choices In Diabetes Everyday) Program Delivery Modalities on Clinical and Behavioral Outcomes in Urban African Americans With Type 2 Diabetes: A Randomized Trial.
    Fitzpatrick SL; Golden SH; Stewart K; Sutherland J; DeGross S; Brown T; Wang NY; Allen J; Cooper LA; Hill-Briggs F
    Diabetes Care; 2016 Dec; 39(12):2149-2157. PubMed ID: 27879359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.
    Tsuyuki RT; Al Hamarneh YN; Jones CA; Hemmelgarn BR
    J Am Coll Cardiol; 2016 Jun; 67(24):2846-54. PubMed ID: 27058907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
    Bertoni AG; Clark JM; Feeney P; Yanovski SZ; Bantle J; Montgomery B; Safford MM; Herman WH; Haffner S;
    J Diabetes Complications; 2008; 22(1):1-9. PubMed ID: 18191071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
    Strom Williams JL; Lynch CP; Winchester R; Thomas L; Keith B; Egede LE
    Diabetes Technol Ther; 2014 Jul; 16(7):421-7. PubMed ID: 24735058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus.
    Gaillard TR; Schuster DP; Osei K
    Ethn Dis; 1998; 8(3):319-30. PubMed ID: 9926902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
    Nichols GA; Joshua-Gotlib S; Parasuraman S
    J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Coordinated Community and Chronic Care Model Team Intervention vs Usual Care on Systolic Blood Pressure in Patients With Stroke or Transient Ischemic Attack: The SUCCEED Randomized Clinical Trial.
    Towfighi A; Cheng EM; Ayala-Rivera M; Barry F; McCreath H; Ganz DA; Lee ML; Sanossian N; Mehta B; Dutta T; Razmara A; Bryg R; Song SS; Willis P; Wu S; Ramirez M; Richards A; Jackson N; Wacksman J; Mittman B; Tran J; Johnson RR; Ediss C; Sivers-Teixeira T; Shaby B; Montoya AL; Corrales M; Mojarro-Huang E; Castro M; Gomez P; Muñoz C; Garcia D; Moreno L; Fernandez M; Lopez E; Valdez S; Haber HR; Hill VA; Rao NM; Martinez B; Hudson L; Valle NP; Vickrey BG;
    JAMA Netw Open; 2021 Feb; 4(2):e2036227. PubMed ID: 33587132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.